Bionano Genomics, Inc.
BNGO
$4.08
-$0.02-0.49%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.33M | 36.58M | 37.47M | 36.12M | 33.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.33M | 36.58M | 37.47M | 36.12M | 33.61M |
| Cost of Revenue | 33.93M | 25.98M | 27.15M | 26.55M | 24.68M |
| Gross Profit | -599.00K | 10.60M | 10.32M | 9.57M | 8.93M |
| SG&A Expenses | 60.43M | 75.86M | 91.24M | 96.70M | 100.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.39M | 143.94M | 168.27M | 177.28M | 181.48M |
| Operating Income | -94.06M | -107.36M | -130.80M | -141.17M | -147.87M |
| Income Before Tax | -135.79M | -204.09M | -226.77M | -232.43M | -225.38M |
| Income Tax Expenses | -4.00K | 11.00K | 18.00K | 62.00K | 1.90M |
| Earnings from Continuing Operations | -135.78 | -204.10 | -226.79 | -232.49 | -227.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -135.78M | -204.10M | -226.79M | -232.49M | -227.28M |
| EBIT | -94.06M | -107.36M | -130.80M | -141.17M | -147.87M |
| EBITDA | -78.84M | -94.15M | -117.27M | -127.46M | -135.01M |
| EPS Basic | -147.13 | -309.18 | -368.90 | -406.90 | -418.98 |
| Normalized Basic EPS | -84.81 | -112.55 | -148.33 | -174.21 | -173.19 |
| EPS Diluted | -147.49 | -309.54 | -369.25 | -407.05 | -419.04 |
| Normalized Diluted EPS | -84.81 | -112.55 | -148.33 | -174.21 | -173.19 |
| Average Basic Shares Outstanding | 4.10M | 3.25M | 2.65M | 2.28M | 2.11M |
| Average Diluted Shares Outstanding | 4.10M | 3.25M | 2.65M | 2.28M | 2.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
